Role of CD19 and Specific KIT-D816 on Risk Stratification Refinement in t(8;21) AML Induced With Different Cytarabine Intensities
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Role of CD19 and Specific KIT-D816 on Risk Stratification Refinement in t(8;21) Acute Myeloid Leukemia Induced With Different Cytarabine Intensities
Cancer Med 2020 Dec 31;[EPub Ahead of Print], B Wang, B Yang, Y Ling, J Zhang, X Hua, W Gu, F YanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.